Activation of microglial cells in response to brain injury and/or immune stimuli is associated with a marked induction of Toll-like receptors (TLRs). While in adult brain, the contribution of individual TLRs, including TLR2, in pathophysiological cascades has been well established, their role and spatial and temporal induction patterns in immature brain are far less understood. To examine whether infectious stimuli and sterile inflammatory stimuli trigger distinct TLR2-mediated innate immune responses, we used three models in postnatal day 9 (P9) mice, a model of infection induced by systemic endotoxin injection and two models of sterile inflammation, intra-cortical IL-1β injection and transient middle cerebral artery occlusion (tMCAO). We took advantage of a transgenic mouse model bearing the dual reporter system luciferase/GFP under transcriptional control of a murine TLR2 promoter (TLR2-luc-GFP) to visualize the TLR2 response in the living neonatal brain and then determined neuroinflammation, microglial activation and leukocyte infiltration. We show that in physiological postnatal brain development the in vivo TLR2-luc signal undergoes a marked ~30 fold decline and temporal-spatial changes during the second and third postnatal weeks. We then show that while endotoxin robustly induces the in vivo TLR2-luc signal in the living brain and increases levels of several inflammatory cytokines and chemokines, the in vivo TLR2-luc signal is reduced after both IL-1β and tMCAO and the inflammatory response is muted. Immunofluorescence revealed that microglial cells are the predominant source of TLR2 production during postnatal brain development and in all three neonatal models studied. 
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CD11b
+ /CD45 + and CD11b + /Ly6C + cell populations, involvement of cells of the monocyte lineage, but lack of Ly6G + neutrophils or CD3 + cells in acutely injured neonatal brains.
Introduction
Neuroinflammation caused by infection, hypoxia-ischemia and stroke during the perinatal period contributes to increased risk for neurological and neuropsychiatric deficits and long term disabilities in children (Hagberg et al., 2015) . Injury-induced inflammatory response is characterized by marked activation of the resident immune cells, microglial cells, and peripheral leukocytes, and production of inflammatory cytokines, events that may contribute to brain damage (Dirnagl et al., 1999; Iadecola and Anrather, 2011; Kriz and Lalancette-Hebert, 2009; Lo et al., 2003) . Microglial cells are the principal immune cells of the brain. The current view is that once activated, microglial cells may acquire a variety of different stimulus-and context dependent immune profiles ranging from pro-inflammatory/cytotoxic to more alternative and neuroprotective phenotypes (Fernandez-Lopez et al., 2014; Pierre et al., 2017) . The role of microglial cells is even more complex in immature brain, as growing evidence suggests that microglial cells play active role during brain development and early CNS homeostasis, in part by enabling neuronal synapse remodelling and phagocytosis of neurons that undergo still on-going programmed cell death in the developing brain (Paolicelli et al., 2011) . Thus, inflammation and microglial activation can actively contribute to both normal physiological development and to injury in neonatal brain.
Upregulation of the pattern-recognition receptors, such as Toll-like receptors (TLRs), by activated microglial cells has been shown in injured adult brain (Akira and Takeda, 2004; Arumugam et al., 2009; Gordon, 2002; Janeway and Medzhitov, 2002; Lalancette-Hebert et al., 2009; Stridh et al., 2011; Ziegler et al., 2007 ) and in immature brain after H-I (Stridh et al., 2011) . TLRs act via recognition of two types of ligands, the pathogen-associated molecular pattern (PAMP) ligands in response to infectious particles (Medzhitov et al., 1997 ) and the endogenous danger-associated molecular pattern (DAMP) ligands in response to stress or injuryderived molecules (Arumugam et al., 2009; Asea et al., 2002; Hanisch et al., 2008; Kariko et al., 2004; Matzinger, 2002) . While some data suggest that immune cascades following activation of TLR receptors, like TLR2 in microglia, may have harmful effect on neonates (Du et al., 2011; Mallard et al., 2009; Mottahedin et al., 2017; Pierre et al., 2017) , the role of the innate immune response in neonatal brain development and/or response to injuries remains poorly understood.
We asked if DAMP and PAMP mediated TLR2 responses lead to distinct neuroinflammatory injury patters in neonatal mice. To visualize TLR2 response in the living neonatal brain we took advantage of a transgenic mouse model bearing the dual reporter system luciferase/green fluorescent protein under transcriptional control of a murine TLR2 promoter (TLR2-luc-GFP), a reporter mouse model that we used to identify induction of TLR2 and associated microglial activation by biophotonic/bioluminescence imaging in living adult mice subjected to stroke Lalancette-Hebert et al., 2012) . We show that TLR2-luc signal undergoes marked ~30 fold decline and regional redistribution during the second and third postnatal weeks and that there are striking differences in the TLR2 response to endotoxin (LPS) challenge compared to sterile inflammation induced by intra-cerebral injection of IL-1 or transient middle cerebral artery occlusion (tMCAO) in postnatal day 9 (P9) mice-a robust upregulation of TLR2-luc by LPS but, surprisingly, a significant down-regulation of the TLR2-luc signal following IL-1 or tMCAO. Together with distinct LPS compared to IL-1 or tMCAO patterns of induction of inflammatory and anti-inflammatory cytokines our results strongly suggest distinct TLR2 induction patterns following PAMP and DAMP-mediated inflammation in immature brain.
Material and methods

Mouse model
TLR2-luc-GFP transgenic reporter mice were used to visualise TLR2 induction/microglial activation, as we described before . Transgenic animals were identified by polymerase chain reaction (PCR) detection of the luciferase transgene with the following primers: 5'-CAG-CAG-GAT-GCT-CTC-CAG-TTC-3' AND 5'-GGC-GCA-GTA-GGC-AAG-GTG-GT-3'. Genotyping was performed as previously described Services). Animals were given ad libitum access to food and water; housed with nesting material and shelters, and kept in rooms with temperature control and light/dark cycles.
In vivo bioluminescence/biophotonic imaging
As previously described (Cordeau et al., 2008; Lalancette-Hebert et al., 2009) , bioluminescence/biophotonic images were captured using IVIS® 200 Imaging System (PerkinElmer, MA, USA). Twenty-five minutes prior to imaging session, mice received intraperitoneal (i.p.) injection of luciferase substrate D-luciferine (150 mg/kg; 20 mg/ml of Dluciferine dissolved in 0.9% saline was injected) (CaliperLS-Xenogen). 3D reconstruction of bioluminescent signal in the brain was accomplished by using diffuse luminescent imaging tomography (DLIT) algorithms (Living Image 3D Analysis Software, CaliperLS-Xenogen) .
Surgical procedures
Stereotaxic IL-1 brain injection
P9 TLR2-luc-GFP pups of both sexes were anesthetized with 2% isoflurane in 100% oxygen at a flow rate of 1.5 l/min and placed in a stereotaxic apparatus (David Kopf Instruments). Mice received stereotaxic intracerebral injection of recombinant IL-1 (1ng) (R&D systems, MN, USA) or sterile saline solution (0.9%) into the right parietal region of cerebral cortex. The coordinates for stereotaxic injection were the following: 2.0 mm posterior, 2.0 mm lateral (right) and -1.25 mm dorsoventral to the bregma. The injections were performed using a 33-gauge stainless steel cannula (Plastics One) connected to a 25-ml Hamilton syringe. A volume of 2 l was infused over 2 min using a microinjection pump (model A-99; Razel Scientific Instruments).
The animals were then longitudinally imaged by in vivo bioluminescence for a week.
Transient middle cerebral artery occlusion (tMCAO)
P9-P10 mice of both sexes with confirmed presence of TLR2-luc-GFP transgene were subjected to 3h tMCAO as originally described for P7 rats (Derugin et al., 2005; Derugin et al., 1998) and modified for P9-P10 mice (Woo et al., 2012) . Mice were administered D-luciferine (150 mg/kg; i.p.) and were imaged 30 min later before tMCAO to obtain baseline and were imaged at 24 and 72 hrs after reperfusion. Mice were either perfusion-fixed for histology or tissue collected from injured regions and from matching contralateral regions for biochemical analysis.
LPS injection
P9 TLR2-luc-GFP pups of both sexes were injected intraperitoneally (i.p.) 1mg/kg of LPS dissolved in 0.9% sterile saline or saline. Mice were longitudinally imaged in vivo before and 1 and 3 days after LPS administration.
Tissue collection
For immunofluorescence analysis, anaesthetized pups were transcardially perfused with 15 ml of 0.1M PBS, followed by 4% paraformaldehyde (PFA, pH 7.4, phosphate buffered saline, PBS).
Brains were postfixed overnight in 4% PFA and cryoprotected in 30% sucrose/ PBS for 48 hrs, embedded into Tissue-Tek (O.C.T. compound, Sakura, USA) and frozen at -20C, cut into coronal section with a Cryostat (15-m thick) and stored at -20C.
Pups that underwent tMCAO were deeply anesthetised with Euthasol (100 mg/kg; Virbac) and perfused transcardially with 4% PFA in 0.1M PBS (pH 7.4). Brains were post-fixed in 4% PFA overnight at 4°C, cryoprotected in 30% sucrose in 0.1 M PBS at 4°C for 48h, frozen and cut on cryostat (12 m thick, 348 m apart).
Immunofluorescence
Brain sections were blocked in 10% goat serum in 0.1M PBS at room temperature for 30 minutes and incubated overnight at room temperature using the following primary antibodies: mouse monoclonal anti GFP (1:750, Santa Cruz), rabbit polyclonal anti-NeuN (1:500, Cell Signaling), rat polyclonal anti CD11b (1:500, Biorad), rat anti Galectin-3 (anti-Gal-3, 1:500, American Type Following tMCAO, sample preparation for multi-color flow cytometry was carried out as we described (Chip et al., 2017) . Briefly, mice were deeply anesthetized and transcardially perfused with 10 ml of ice-cold saline (Mg2+ and Ca2+ free Hanks Balance Salt Solution). Cortices were collected and dissociated using Neural Tissue Dissociation Kit containing papain (Miltenyi Biotec), filtered through 40 μm cell strainer, followed by myelin removal with myelin- 
Statistical analysis
All data are presented as mean ± SEM. Statistical analysis was performed by one-way ANOVA followed by post hoc comparison test (Tukey-Kramer test) or unpaired t-test. ***p≤0.001 ** p≤0.01 and *p≤0.05.
Results
TLR2 biophotonic/bioluminescence signal is high in the early postnatal brain and declines with brain maturation
It has been established that TLRs are the key mediators of the immune response to invading pathogens and/or of brain injury in both adult and immature brain. Growing evidence suggests that after birth, the role of the innate immune response may differ depending on the context and the stage of brain development (Hagberg et al., 2015) . However, developmental patterns of higher than the signal during early adult age; compared to that at P28, TLR2-luc signal was 33 fold higher in P6 and 27 fold higher at P9 (Fig.1M ). In addition, 2D analysis of images pointed to the presence of age-dependent regional pattern of TLR2-luc signal. To confirm that TLR-luc signal is indeed arising from the distinct brain regions in different age groups, we performed in vivo spectral imaging followed by DLIT analysis of the brain images .
As shown in Fig. 1I -L, 3D reconstruction of the TLR2-luc signal further confirmed a distinct, age-dependent neuroanatomical distribution of the TLR2-luc signal. In fact, while at P8 TLR2 expression is strong and is located in many different regions of the brain ( Fig.1 I) , in mature brain identifiable TLR2-luc signal becomes restricted to the olfactory bulb region, consistent with our previous observations in adult mice . Additional analysis of the TLR2-luc signal is shown in supplemental figure 1.
We then took advantage of the dual nature of the TLR2-luc-GFP reporter mouse that coexpresses the firefly-luciferase (Luc) and green fluorescent protein (GFP) under the murine TLR2 promoter. In this model, the fluorescence signal can be used to identify the overall GFP signal, regional TLR2 expression patterns during postnatal development and the cellular origin of the signal in fixed tissue of mice that underwent in vivo imaging. In the cortex of P6 and P8 mice, GFP + cells showed ramified microglial morphology ( expression between P6-P8 remained unchanged followed by a significant decrease at P14. We observed a progressive decline of GFP expression from P6 to P18 in the corpus callosum ( Fig.1 Z). In the choroid plexus, GFP expression was markedly higher than in the cortex and/or corpus callosum ( Fig.1 W) . These results are consistent with the regional distribution and the intensities of the TLR2-luc signal observed by live imaging. Next, to identify the cell types expressing the TLR2 driven transgene GFP we performed double-immunofluorescence analysis with cell-type specific markers, including microglial markers CD11b and Gal-3 (galectin-3), neuronal progenitor marker (DCX), neuronal marker (NeuN), astrocyte marker GFAP and endothelial cells/activated microglia marker IB4. Analysis showed that GFP + cells are almost exclusively CD11b + in the cortex (Fig.2 A-D ) and in the corpus callosum ( Fig.2 E-H Taken together, bioluminescence imaging, including 3D reconstruction and analysis of cells identified by FACS, in conjunction with region-specific immunofluorescence analysis revealed the overall marked decline of the TLR2-luc signal and GFP expression and region-specific changes in localization during postnatal brain maturation. Based on expression patterns of the TLR2 driven GFP, with the exception of the choroid plexus region, in control, physiological conditions the TLR2 signal is induced/expressed in resident microglial cells.
Systemic LPS injection rapidly induces TLR2 in neonatal brain
We previously reported in the adult that systemic LPS injection induces marked TLR2 upregulation in resident microglial cells peaking 24 hrs after initial challenge (Gravel et al., 2016; Lalancette-Hebert et al., 2009) . Data by others have demonstrated that LPS injection induces microglial activation in neonatal brains (Claypoole et al., 2016; Du et al., 2011) .
Considering that in neonatal brain TLR2 expression is already high under physiological conditions, we asked whether LPS further upregulates TLR2. Analysis of biophotonic/bioluminescence signal revealed an additional robust increase in the TLR2-luc signal following LPS challenge, with the peak at 24 hrs after injection ( Fig. 3 A-B and G), followed by a decline to basal level 48-72 hrs after initial stimuli ( Fig. 3 C-F and G). Consistent with in vivo imaging data, western blot analysis revealed a significant increase of both TLR2 and Iba1 protein expression 24 hrs after LPS (Fig.3 H-J) .
In order to characterize a molecular signature of LPS challenge in neonatal brain we measured levels of the key inflammatory and anti-inflammatory cytokines known to be involved in control of the acute innate immune response. Cytokine array analysis 24 hrs after LPS injection demonstrated significant increase in protein expression of 10 studied pro-inflammatory cytokines as compared to saline-injected mice, including TNF- (Fig.3 K) , IL-1 (Fig.3 L) , IL-17 (Fig.3 M), IL-6 (Fig.3 N) , INF- (Fig.3 O) and MCP-1 (Fig.3 T) . Importantly, LPS also significantly increased the levels of several anti-inflammatory cytokines, including IL-4 (Fig.3 P) and IL-10 ( Fig.3 Q) , as well as growth factors M-CSF (Fig.3 R) and GM-CSF (Fig.3 S) .
We next investigated cell types that upregulate TLR2 after systemic LPS challenge and whether LPS activates microglial cells in neonatal brains. Following LPS injection, double immunofluorescence analysis with cell type specific markers revealed GFP + /CD11b + cells in the cortex (Fig. 4 A-H), corpus callosum (Fig. 4 J-Q) and choroid plexus (Fig. 4 S-Z) . Examination of microglial morphology also revealed thickening of microglial processes and acquisition of amoeboid morphology in the cortex (Fig. 4 A and E) and corpus callosum ( (Chen et al., 2012) , the cellular response to LPS in immature brain is less well characterized (Cazareth et al., 2014; Pierre et al., 2016) . Namely, report by Carrillo-de Savage and colleagues suggests that (Carrillo-de Sauvage et al., 2013) intraparenchymal injection of LPS may induce cell proliferation and/or infiltration of myeloid cells from the periphery. To decipher cellular components of LPS -mediated innate immune response and TLR2-luc signal induction in immature brain, we performed flow cytometry. As described above, we first gated single cells on CD45 and CD11b (see Fig. 2 ). Compared to vehicle injected mice (Fig.5 A, caused predominantly by a marked activation of resident microglial cells (Chen et al., 2012) .
Brain response following IL-1β injection and focal arterial stroke in neonates is characterized by downregulation of the innate immune response
Recent studies suggest that TLR2 may have age-dependent role in the brain response to injury and associated DAMPS (Eklind et al., 2004; Mallard et al., 2009) . Therefore, we analyzed the TLR2 signal patterns in living brains in two different models of brain injury in neonatal mice, following intra-cortical IL-1 injection or tMCAO.
Intracortical IL-1 injection mutes the inflammatory response and does not induce TLR2
Previous evidence of the inflammatory response by intracortical IL-1 injection in pups yielded conflicting results (Cai et al., 2004; Wang et al., 2011) . Some studies suggested that IL-1 does not induce strong microglial activation (Cai et al., 2004) , while others reported a role of IL-1 injection in inflammation in chronic pain and/or neuronal death . We reported increased IL-1 in the blood and then in injured brain regions in a neonatal rat stroke model (Denker et al., 2007) , but lesser magnitude of effects in a neonatal mouse stroke model (Woo et al., 2012) . We imaged P9 TLR2-luc-GFP mice following IL-1 injection or vehicle and observed a significant decrease of the TLR2-luc signal compared to that in saline injected mice at 24 hours ( Fig. 6 A-B, G) . A further significant decrease of the TLR2-luc signal was observed 2 days after injection in both saline or IL-1 treated mice (Fig. 6G) , consistent with developmental decline in the TLR2 signal (Fig 1) . The observed decrease in the TLR2-luc signal in vivo was further confirmed by western blot analysis (Fig. 6 H) , In fact, consistent with in vivo imaging data, quantification of TLR2 and Iba1 protein levels revealed a significant decrease 24 hrs after IL- injection (Fig. 6 I-J) . In keeping with the observed decrease in the TLR2-luc signal, compared to saline treated mice, the levels of several studied cytokines were significantly lower in the brains of IL-1 injected mice, Quantitative cytokine array analysis revealed a significant decrease in the levels of IL1β, Il-17, IL-6, IFNγ and GM-SCF. The levels of TNF-,
IL-4 and M-CSF remained unchanged (Fig.6 K-T).
Interestingly, double immunofluorescence showed distinct cell type specific distribution of the TLR2-GFP signal adjacent to and distant from the injection site 24 hrs after injection.
While adjacent to the injection site, in saline ( Fig.6 U 
Lack of acute TLR2 induction in neonatal TLR2-luc-GFP mice after acute tMCAO
Given markedly different innate immune responses following LPS challenge and in a sterile brain injury induced by IL-1β injection, we asked if tMCAO in P9-P10 mice, another type of sterile injury, affects the innate response. Our previous studies in neonatal rat and mouse stroke tMCAO models have shown that microglial cells contribute to endogenous protection, at least during acute and subchronic injury phases (Faustino et al., 2011; Fernandez-Lopez et al., 2016) , and that mRNA levels for several TLRs remain mostly unchanged in ischemic-reperfused brain regions as well as in microglial cells acutely dissociated from neonatal brain 24 hrs after tMCAO (Li et al., 2015) . In this study we determined TLR2-luc signal after tMCAO directly in the living neonatal TLR2-luc-GFP brain (Fig. 7 A-E) . Quantification of the TLR2-luc signal in the entire brain 24 hrs after reperfusion showed the overall significant reduction of TLR2-luc signal ( Fig. 7 B and D) and restoration of the signal by 72 hrs. Compared to contralateral hemisphere, TLR2-luc signal was significantly higher in most injured mice but not in all mice ( Fig. 7 C and E) . Measurements of injury in Nissl-stained brains confirmed consistent injury in all imaged mice, with injury volume occupying 34.5 ± 3.5% of ipsilateral hemisphere (n=7). In addition, we used the presence of a characteristic pattern of spectrin cleavage by calpaindependent mechanism (150kDa, Fig. 7F ) or by caspase-3 mechanism (120kDa, Fig. 7F ) to confirm successful occlusion of the MCA in mice designated for biochemical measurements, method that we extensively used in the past (Chip et al., 2017; Fernandez-Lopez et al., 2016; Li et al., 2015; Woo et al., 2012) . Unilateral TLR2 upregulation was observed in injured regions at 72 hrs but not at 24 hrs after tMCAO ( Fig. 7 C and E), consistent with in vivo imaging results ( Fig. 7A-C) .
Analysis of cellular origin of the TLR2 driven GFP transgene by double immunofluorescence revealed that essentially all GFP + cells were IB4 + activated microglial cells in the ischemic core and penumbra ( Fig. 7 G-N) and that only a small fraction of GFP + cells were GFP + NeuN + cells (Fig. 7 G-N) , again showing that microglia/macrophages are the predominant cell type expressing TLR2 under sterile inflammation. Consistent with in vivo TLR2-luc data, the strongest TLR2-GFP signal was observed in the choroid plexus ( Fig. 7 O-Q).
Multiple cytokine array analysis 24 hrs after tMCAO showed significantly decreased levels of major pro-inflammatory cytokine in injured compared to matching contralateral regions, including TNF- (Fig.8 A) , IL-1 (Fig.8 B) , IL-17 (Fig.8 C) and INF (Fig.8 E) . On the opposite, the level of IL-6 (Fig.8 D) and MCP-1 (Fig.8 J) were significantly increased in injured regions. Protein levels of anti-inflammatory cytokines IL-4 and IL-10 and growth factors M-CSF and MGM-CSF were not significantly changed compared to those in matching contralateral regions (Fig. 8) .
We then asked if injury was associated with infiltration of monocytes and neutrophils.
Using a strategy described in Fig. 2 M-O, we gated on single cells from whole tissue lysates (Fig.   8K ) and used unstained negative control (Fig. 8L) to identify CD11b + CD45 + population in contralateral (Fig. 8 M) and injured (Fig. 8O) regions. As we previously reported, there was a shift in signal intensity and accumulation of CD11b + CD45 + cells (Fig. 8 M-O) (Chip et al., 2017; Li et al., 2015) . There was only a small (<1%) CD11b + CD45 + Ly6G + subpopulation in both contralateral (Fig. 8 N) and injured ( Fig. 8 P) regions, indicating minimal neutrophil infiltration after tMCAO.
Discussion
The innate immune response is a fundamental mechanism involved in the regulation of brain inflammation caused by sterile inflammation or by infection, but the relative role of individual TLRs under sterile and infectious stimuli is less well characterized. In this study, we report that TLR2 is highly expressed in early postnatal brain, between P6-P9, that TLR2 expression rapidly decreases with postnatal brain maturation under physiological conditions and becomes restricted to the olfactory bulb at P28. Importantly, flow cytometry revealed that the observed in vivo TLR2-luc signal indeed originates from activated resident brain microglia/macrophages. We then show that bacterial inflammation caused by systemic LPS injection induces TLR2 in microglial cells and promotes synthesis and/or secretion of inflammatory mediators, whereas sterile inflammation, induced by either intra-cortical IL-1 injection or tMCAO, downregulates the innate immune response, limits TLR2 induction and blunts production of inflammatory cytokines. While microglial cells are the predominant cell type that expresses TLR2 in all injury models studied, our findings indicate a scenario-specific adaptable role of the innate immune response as a reaction to injury or infection in neonates.
The inflammatory response is a defense reaction against divers insults designed to remove noxious agents and to limit their detrimental effects. TLRs are active responders to and mediators of infection as well as sterile inflammation and brain injury in stroke. While TLR4 seems to be purely injurious in both experimental stroke (Kilic et al., 2008; Lehnardt et al., 2007; Saito et al., 2000) and human stroke (Beschorner et al., 2002) , the role of TLR2 is more complex. Namely, it appears that TLR2 may elicit context-and tissue-dependent effects that are either injurious (Abe et al., 2010; Ziegler et al., 2007) or beneficial (Hua et al., 2009; Rolls et al., 2007) based on the type(s) of heterodimers that it forms with TLR1 and TLR4 (Abe et al., 2010) . While TLR downstream signaling pathways are relatively well described, the mechanisms facilitating ligand recognition by TLRs remain poorly understood. While we and others have shown that timely TLR2 induction is needed after brain injury to limit evolution of brain damage in the adult Lalancette-Hebert et al., 2007) , the role of inflammation and innate immunity is more complex in injured immature brain. For example, in the developing brain, the role of TLR receptors is context-dependent-bacterial Vs. sterile-and agedependent-term brain Vs. preterm brain (Mallard et al., 2009 ). In the hypoxia-ischemia model at term, neither TLR2 agonist (Eklind et al., 2004) nor genetic deletion of TLR2's downstream affecter, MyD88 (Mallard et al., 2009) , affect injury, whereas genetic TLR2 deletion decreases infarct volume (Stridh et al., 2011) . At the same time, systemic LPS-induced TLR4 stimulation and TLR2 stimulation by its ligand Pam3CSK4 during P3-P11 produce differing responses at P12 (Du et al., 2011) . Pam3CSK4-induced TLR2 activation in P9 mice exerts robust leukocyte trafficking via the choroid plexus (Mottahedin et al., 2017) . Interestingly, Pam3CSK4 but not LPS induces IL-1β when stimulation occurs in the premature brain (Stridh et al., 2011) . While IL-1β is generally considered injurious, genetic manipulations of the pathway showed rather complex effects on hypoxia-ischemia injury in neonatal brain (Doverhag et al., 2010; Girard et al., 2008; Savard et al., 2015; Stridh et al., 2011) . TLR2 is regulated in hypoxia-ischemia and by LPS (Triantafilou and Triantafilou, 2002) , counteracting the proliferation of neuronal progenitor cells and leading to defects in brain plasticity and behaviour (Yuan et al., 2010) .
Considering that it is becoming increasingly clear that innate immune system activation can modulate postnatal brain development (Bsibsi et al., 2002; Jack et al., 2005; Yuan et al., 2010) and that timely modulation of innate immunity is instrumental in the early brain homeostasis and brain development, we investigated in vivo TLR2 expression in normally developing brain and in injured neonatal brain in the context of systemic bacterial challenge and in two models of sterile brain injury. Our results revealed a markedly higher TLR2 expression in multiple brain regions, most prominently in the choroid plexus and in the corpus callosum in early postnatal period, that declines by P28. As in adult brain (Andreasson et al., 2016; Grabert et al., 2016; Lawson et al., 1990; Olah et al., 2011) , we also observed a broad range of microglial morphologies in immature brain. We demonstrate that GFP + cells are mainly resident microglia/macrophages during physiological brain development and that while microglial cells have a more ''activated-like'' amoeboid round shape morphology at P6, they undergo ramification by P14, in parallel with a decrease in the CD11b + /CD45 high cell population. As suggested by others, this may be in part related to a decline in neuronal programmed cell death and reduced pruning by P14 (Ikonomidou et al., 1999 ) (Paolicelli et al., 2011) . Importantly, upon both types of injury, resident microglia/macrophages remain the principal cell type expressing TLR2, with only a few NeuN + cells within injured regions.
The detrimental effects of microglial activation has been linked to induction of pattern recognition receptors, TLRs, implicated in response to danger signals in the brain. Viral or bacterial infections are associated with significant lifelong deficits and mortality (Muller, 2016) .
For example, 40% of newborns who survive herpes, encephalitis or sepsis develop neurologic impairments (Mwaniki et al., 2012) . LPS has been shown to induce microglial activation, TLR2 expression in the CNS and production of pro-inflammatory cytokines like IL-1 and IL-6 (Laflamme et al., 2001; Monje et al., 2003; Strunk et al., 2014; Turrin et al., 2001; Vallieres and Rivest, 1997) . Consistent with this notion, we observed a strong transient increase in TLR2-luc signal 24 hrs after LPS administration, which was accompanied by an increase in several major inflammatory cytokines, but anti-inflammatory cytokines as well. The increase in cytokine production can probably be attributed to resident glial cells since it has been shown that, although LPS can cause the release of CCl5 and MCP-1 in the brain, it does not promote a significant leukocyte infiltration into brain parenchyma, at least not early (Mottahedin et al., 2017 Previous studies have shown that TLR expression can be regulated in a stimulus-dependant and cell-type specific manner (Iwasaki and Medzhitov, 2004; Muzio et al., 2000; Visintin et al., 2001; Yoon et al., 2008) . IL-1β administration is often used as a model of apoptotic cell death despite controversial reports (Allan, 2002; Cai et al., 2004; Holmin and Mathiesen, 2000; Iwasaki and Medzhitov, 2004; Loddick and Rothwell, 1996; Muzio et al., 2000; Patel et al., 2003; Visintin et al., 2001; Yoon et al., 2008) . Here, we show that at 24 hrs neither IL-1 injection nor tMCAO increase TLR2 expression and/or induce marked inflammatory cytokine production. These data are consistent with our earlier observations that microglial cells are intrinsically protective after neonatal stroke (Faustino et al., 2011; Fernandez-Lopez et al., 2014) and that injury is not associated with increased TLR2/3/4 gene induction 24-72 hrs after neonatal stroke (Li et al., 2015) . Considering that cytokines produced in microglia vs. monocytes can exert distinct or even opposite effects in stroke (Lambertsen et al., 2009) , it would be important to understand the relative contribution of microglial cells Vs. monocytes into injury. This important question continues to be unresolved because microglia and monocytes share a vast majority of antigens and antibodies to antigens specific to either microglia or monocytes are not commercially available. While we share the same limitations, we demonstrate the predominant presence of CD11b + /CD45 + /Ly6C low cells in naïve brains and in brains following IL-1 injection or tMCAO, a population comprised of activated microglial and beneficial monocytes.
Our findings show that in distinct kinds of injury to neonatal brain-infectious or sterile-the cytokine response is vastly different, but that the main TLR2 expressing cell type are microglial cells. These observations raise a fundamental question about whether similar or distinct signal transduction repertoires in microglial cells are involved under the studied conditions. Given the presence of an array of inducible molecules in microglia in the adult (Lucin and Wyss-Coray, 2009 ) and that both brain immaturity and microglial cell immaturity greatly affect the function of microglial cells (Butovsky et al., 2014; Hagberg et al., 2015) , it is likely that an interplay between many pathways exert the differential response.
In conclusion, we show for the first time that TLR2 expression is age-dependent under both physiological conditions as well as after injury, that the involvement of TLR2 in stroke in the adult and in the neonate is vastly different, and that the underlying "signatures" of the TLR2
response to sterile and non-sterile inflammation are vastly different. This study raises many questions important for translational research, because the improved understanding of TLR2-mediated microglia-mediated responses to infection or injury would allow for identification of new pharmacological targets. Furthermore, the enhanced understanding of how to use TLR signalling to precondition the susceptible neonates or neonates who are at higher risk for stroke or hypoxia-ischemia due to infection in utero, would allow us to minimize long-term consequences of injury during the neonatal period. 
